{"product_id":"nonalcoholic-fatty-liver-disease-9780470673171","title":"NonAlcoholic Fatty Liver Disease","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eThe sharp rise in cases of Non-alcoholic fatty liver disease is fast becoming one of the major concerns for hepatologists worldwide.This comprehensive clinical guide explains how to diagnose NAFLD and manage patients according to the best standards of care. Contributors from the world''sleading institutions concentrate on patient care, drawing on their extensive experience.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTrade Review\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e“This book is useful for anyone who cares for patients with NAFLD -- specialist or generalist. It provides both a general overview as well as a detailed look at disease mechanisms, clinical assessment, diagnosis, and treatment. It comes out in a timely fashion as diseases such as diabetes, obesity, metabolic syndrome, NAFLD, and NASH are on the rise.”  (\u003ci\u003eDoody’s\u003c\/i\u003e, 24 January 2014)\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003cp\u003eList of Contributors, vii\u003c\/p\u003e \u003cp\u003e1 What is non-alcoholic fatty liver disease (NAFLD), and why is it important? 1\u003cbr\u003e \u003ci\u003eGeoffrey C. Farrell, Arthur J. McCullough, and Christopher P. Day\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e2 NAFLD in the community, 17\u003cbr\u003e \u003ci\u003eLeon A. Adams\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e3 Pathology of NAFLD, 27\u003cbr\u003e \u003ci\u003eElizabeth M. Brunt and David E. Kleiner\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e4 The natural history of NAFLD, 37\u003cbr\u003e \u003ci\u003ePaul Angulo\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e5 Emerging concepts on the pathogenesis of non-alcoholic steatohepatitis (NASH), 46\u003cbr\u003e \u003ci\u003eIsabelle A. Leclercq\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e6 Diabetes and NAFLD: why is the connection important? 62\u003cbr\u003e \u003ci\u003eElisabetta Bugianesi\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e7 NAFLD and cardiovascular risk factors: implications for vascular disease, 71\u003cbr\u003e \u003ci\u003eGiovanni Targher\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e8 A primary care perspective of fatty liver: diagnosis, management, prescribing, and when to refer, 84\u003cbr\u003e \u003ci\u003eShivakumar Chitturi and Geoffrey C. Farrell\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e9 Imaging of NAFLD, 93\u003cbr\u003e \u003ci\u003eTakeshi Yokoo, An Tang, and Claude B. Sirlin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e10 Non-invasive methods to determine the severity of NAFLD and NASH, 112\u003cbr\u003e \u003ci\u003eVincent Wai-Sun Wong and Henry Lik-Yuen Chan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e11 Fatigue, quality of life, and psychosocial issues for people with NAFLD, 122\u003cbr\u003e \u003ci\u003eJulia L. Newton and James Frith\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e12 Physical activity and cardiovascular fi tness in patients with NAFLD: clinical importance and therapeutic implications, 132\u003cbr\u003e \u003ci\u003eIngrid J. Hickman, Graeme A. Macdonald, and Nuala M. Byrne\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e13 NAFLD, obesity, and bariatric surgery, 149\u003cbr\u003e \u003ci\u003ePhilippe Mathurin\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e14 Genetic predisposition to NAFLD and NASH: implications for pathogenesis, diagnosis, prevention, and management, 157\u003cbr\u003e \u003ci\u003eQuentin M. Anstee, Ann K. Daly, and Christopher P. Day\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e15 NAFLD in children, 171\u003cbr\u003e \u003ci\u003eAriel E. Feldstein\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e16 The pointy end of the NAFLD iceberg: cirrhosis, portal hypertension, and liver failure, 182\u003cbr\u003e \u003ci\u003eJonathon W. Schwake, Dawn M. Torres, and Stephen A. Harrison\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e17 Non-alcoholic fatty liver disease, hepatocellular cancer, and other cancers, 192\u003cbr\u003e \u003ci\u003eJanine Graham and Helen L. Reeves\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e18 NAFLD in Chinese and South Asian people, 206\u003cbr\u003e \u003ci\u003eJia-Horng Kao, Deepak Amarapurkar, and Jian-Gao Fan\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e19 Non-alcoholic fatty liver disease in Japan, 217\u003cbr\u003e \u003ci\u003eTakeshi Okanoue, Kohichiroh Yasui, and Yoshito Itoh\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e20 Non-alcoholic fatty liver disease in South America and Hispanic people, 228\u003cbr\u003e \u003ci\u003eHelma Pinchemel Cotrim and Carla Daltro\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e21 Alcohol in non-alcoholic fatty liver disease: an oxymoron or a new standard of care?, 234\u003cbr\u003e \u003ci\u003eAchuthan Sourianarayanane, Srinivasan Dasarathy, and Arthur J. McCullough\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e22 Dietary factors in the pathogenesis and care of patients with fatty liver disease, 248\u003cbr\u003e \u003ci\u003eGiulio Marchesini, Rebecca Marzocchi, Anna S. Sasdelli, Cristiana Andruccioli, and Silvia Di Domizio\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e23 Metabolic factors and steatosis in patients with hepatitis B and C, 260\u003cbr\u003e \u003ci\u003eFrancesco Negro\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e24 Drug therapy for NASH: insulin-sensitizing agents (metformin and thiazolidinediones), 271\u003cbr\u003e \u003ci\u003eMohammad S. Siddiqui and Arun J. Sanyal\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e25 Hepatoprotectants against fatty liver disease: antioxidants, ursodeoxycholic acid, and herbal medicines, 284\u003cbr\u003e \u003ci\u003eAnne Catherine Bürgi and Jean-François Dufour\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003e26 Lipid modifiers and NASH: statins, ezetimibe, fibrates, and other agents, 293\u003cbr\u003e \u003ci\u003eGiovanni Musso, Federica Molinaro, Elena Paschetta, Roberto Gambino, and Maurizio Cassader\u003c\/i\u003e\u003c\/p\u003e \u003cp\u003eIndex, 308\u003c\/p\u003e \u003cp\u003eColor plate section facing p86\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49525387034967,"sku":"9780470673171","price":117.95,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9780470673171.jpg?v=1731860321","url":"https:\/\/bookcurl.com\/products\/nonalcoholic-fatty-liver-disease-9780470673171","provider":"Book Curl","version":"1.0","type":"link"}